Canada Circulating Tumor Cells Market Size & Outlook
Canada circulating tumor cells market, 2018-2030 (US$M)
Related Markets
Canada circulating tumor cells market highlights
- The Canada circulating tumor cells market generated a revenue of USD 400.3 million in 2023 and is expected to reach USD 999.3 million by 2030.
- The Canada market is expected to grow at a CAGR of 14% from 2024 to 2030.
- In terms of segment, ctc detection & enrichment methods was the largest revenue generating technology in 2023.
- CTC Analysis is the most lucrative technology segment registering the fastest growth during the forecast period.
Circulating tumor cells market data book summary
| Market revenue in 2023 | USD 400.3 million |
| Market revenue in 2030 | USD 999.3 million |
| Growth rate | 14% (CAGR from 2023 to 2030) |
| Largest segment | Ctc detection & enrichment methods |
| Fastest growing segment | CTC Analysis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis |
| Key market players worldwide | Qiagen NV, Bio-Techne Corp, Praxis Precision Medicines Inc Ordinary Shares, Aviva PLC, Biocept Inc, Neurocrine Biosciences Inc, Greiner Bio-One, Miltenyi Biotec, Icon PLC, Ecolab Inc, Arcus Biosciences Inc, Epic Corp, Screen Holdings Co Ltd, Menarini Group, Vtex Ordinary Shares - Class A, Sysmex Corp, STEMCELL Technologies |
Other key industry trends
- In terms of revenue, Canada accounted for 3.5% of the global circulating tumor cells market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. circulating tumor cells market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 999.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Circulating Tumor Cells Market Scope
Circulating Tumor Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada circulating tumor cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to circulating tumor cells market will help companies and investors design strategic landscapes.
Ctc detection & enrichment methods was the largest segment with a revenue share of 66.48% in 2023. Horizon Databook has segmented the Canada circulating tumor cells market based on ctc detection & enrichment methods, ctc direct detection methods, ctc analysis covering the revenue growth of each sub-segment from 2018 to 2030.
The branded generics market in Canada is expected to witness substantial growth due to favorable government policies and increase in strategic initiatives. These initiatives support key generic manufacturers in facilitating import and entry of generic products.
An article published in 2017 suggested that around 71% of the U.S. patient population prefers buying medicines imported from Canada, which presents an opportunity for branded generic drug manufacturers. This is because FDA recommends importing generics from countries with equally high regulatory standards.
In addition, hormonal infertility issues are anticipated to boost market growth. According to a report published by Canada’s government in 2019, around one in six couples reports infertility in Canada. Some of the major causes of infertility in women are hormonal imbalance and endometriosis.
Reasons to subscribe to Canada circulating tumor cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada circulating tumor cells market databook
-
Our clientele includes a mix of circulating tumor cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada circulating tumor cells market , including forecasts for subscribers. This country databook contains high-level insights into Canada circulating tumor cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada circulating tumor cells market size, by technology, 2018-2030 (US$M)
Canada Circulating Tumor Cells Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
